Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer
Yuan Yuan(Cedars-Sinai Medical Center), John H. Yim(Novo Nordisk (United States))
Cited by 33
Related Papers
Liver diseases: epidemiology, causes, trends and predictions
|Signal Transduction and Targeted Therapy|2025|205
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
|Nature Medicine|2025|189
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
|Journal of Hematology & Oncology|2011|120
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
|Molecular Cancer|2015|93
Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).
|Journal of Clinical Oncology|2020|68